Add Yahoo as a preferred source to see more of our stories on Google. A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...

A new drug combination may benefit men whose prostate cancer has returned after primary surgery or radiation therapy. Pairing enzalutamide, an androgen receptor blocker, with the hormone therapy drug ...

The rate of people dying from cancer in the United States continued to decline for the 26th year in a row, according to a new American Cancer Society report. From 2016 to 2017, the United States saw ...

Prostate cancer rates have risen in recent years, with a sharp increase in cases diagnosed in advanced stages, the American Cancer Society said Tuesday. Diagnoses of prostate cancer rose 3% annually ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

Starting next year, Louisiana could require health insurance plans to cover prostate cancer screenings starting at age 40, ...

Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments have been game-changers for lung cancer and skin cancer, prostate cancer ...